Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02517593 · ClinicalTrials.gov registry record · Phase 1

Genetic Risk Estimation of Breast Cancer Prior to Preventive Medication Uptake

A Phase 1 study of Breast Cancer, sponsored by Mayo Clinic.

Completed
Registry status
Phase 1
Development phase
151
Enrollment target
2
Study locations

NCT02517593: Completed Phase 1 study of Breast Cancer, sponsored by Mayo Clinic.

NCT02517593 is a Phase 1 study of Breast Cancer that has completed, run by Mayo Clinic. The registered enrollment target is 151 participants, below the 2,803-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (95% lower). The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02517593, a Phase 1 study of Breast Cancer, has completed, sponsored by Mayo Clinic.

COMPLETED
Registry status
Phase 1
Development phase
151 participants
Enrollment target
2
Study locations

Study Summary

The primary aim of this study is to determine if the addition of an individual polygenic risk score (PRS), in addition to the standard National Cancer Institute's Breast Cancer Risk Assessment Tool (BCRAT) or Tyrer-Cuzick (IBIS) score, will aid women at risk of breast cancer in making a decision to take (or not take) medications to prevent breast cancer

Conditions Studied

Breast Cancer

Interventions

  • GENETIC Polygenic Risk Score

Study Locations (2)

Minnesota

  • Mayo Clinic in Rochester - Rochester

Manitoba

  • CancerCare Manitoba - Winnipeg

Trial Details

FieldValue
Enrollment Target 151 participants
Start Date 2016-03
Est. Completion 2019-12-01
Phase Phase 1

Sponsor

Mayo Clinic

2,844 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT02517593

The ClinicalTrials.gov registry entry for NCT02517593 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 151 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,803-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (95% lower). The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Breast Cancer appearing as the primary indexed condition, and to 1 intervention - of which Polygenic Risk Score is the first listed.

NCT02517593 reports 2 study locations spanning 2 distinct geographic areas - top geographies include Minnesota, Manitoba.

Frequently Asked Questions

What is clinical trial NCT02517593 about?

NCT02517593 is a clinical study titled "Genetic Risk Estimation of Breast Cancer Prior to Preventive Medication Uptake". The primary aim of this study is to determine if the addition of an individual polygenic risk score (PRS), in addition to the standard National Cancer Institute's Breast Cancer Risk Assessment Tool (BCRAT) or Tyrer-Cuzick (IBIS) score, will aid women at risk of breast cancer in making a decision to ...

What is the current status of trial NCT02517593?

This trial is currently completed. It is a Phase 1 study. The enrollment target is 151 participants. The study started on 2016-03. Estimated completion is 2019-12-01.

What conditions does trial NCT02517593 study?

This clinical trial studies the following conditions: Breast Cancer.

What interventions are being tested in trial NCT02517593?

The interventions under investigation include: Polygenic Risk Score (GENETIC).

Who is sponsoring clinical trial NCT02517593?

This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02517593 being conducted?

This trial has 2 study locations across Minnesota, Manitoba. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Breast Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Breast Cancer

All registered trials for this condition

Minnesota

All trials with a study site in Minnesota

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Related

Compare this shortlist side-by-side

Read our methodology - how this data is sourced, computed, and verified.
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.